Dallas, TX -- (SBWIRE) -- 03/22/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
Sealed Air Corp (NYSE:SEE) shares declined 2.88% and closed at $23.58. The company, on Mar. 21, announced the closing of the previously announced offering of $425 million aggregate principal amount of 5.25% senior notes due 2023 (the "Notes"). The Notes were sold to investors at 100.0% of their aggregate principal amount. The Company is using the net proceeds from the offering of the Notes, along with cash on hand, to repurchase and satisfy and discharge all of its outstanding 7.875% Senior Notes due 2017.
Get Latest News, Updates on SEE Here
The Dow Chemical Company(NYSE:DOW) shares decreased 2.87% to $32.48. Dow Water & Process Solutions (DW&PS), a business unit of DOW, on Mar. 21, has entered into a collaboration agreement with Ahlstrom, a global high-performance fiber-based materials company, to use Ahlstrom Disruptor® technology for drinking water applications.
Additionally, the company, on Mar. 18, announced that it plans to tap cheaper shale gas in North America by building several new specialty production plants on the Gulf Coast. The Michigan-based chemical maker aims to produce plastics onshore for use in areas such as transportation and telecommunications.
Is DOW a Strong Buying Opportunity After The Recent Slump? Find out Here
Accenture Plc(NYSE:ACN) shares decreased 2.86% to $74.30 in the last trading session. Stifel Nicolaus maintained Accenture plc on Mar. 20 with a Buy and raised the price target from $79.00 to $80.00.
Additionally, the company, on Mar. 15, received a high vendor assessment for its Accenture CAS Trade Promotion Management (TPM) software solution in Gartner Inc.'s recently published "Vendor Panorama for Trade Promotion Management in Consumer Goods.
Is ACN Signaling a Buy After The Sudden Gain? Don’t Miss Out Free Trend Analysis Here
Dendreon Corporation (NASDAQ:DNDN) shares fell 2.86% and closed at $5.10. The company, on Feb. 25, provided a quarterly loss versus a year-ago profit as revenue fell and restructuring costs weighed on the biotechnology company. The fourth-quarter loss was $38.7 million, or 26 cents per share, compared with a profit of $38.1 million, or 26 cents per share. Quarterly revenue fell to $85.5 million from $202.1 million a year ago.
Is DNDN Signaling a Buy After The Sudden Gain? Don’t Miss Out Free Trend Analysis Here
Marketbuzzreport.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Marketbuzzreport.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.marketbuzzreport.com
The assembled information disseminated by Marketbuzzreport.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Marketbuzzreport.com does expect that investors will buy and sell securities based on information assembled and presented in Marketbuzzreport.com. PLEASE always do your own due diligence, and consult your financial advisor.
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)